Evidence map›Paper›PMID 29619555›Full record

ArticleVirchows Archiv : an international journal of pathology2018

Prognostic significance of 1p36 locus deletion in adenoid cystic carcinoma of the salivary glands.

Petr Šteiner, Simon Andreasen, Petr Grossmann, Lukáš Hauer, Tomáš Vaněček, Markéta Miesbauerová, Thalita Santana, Katalin Kiss, David Slouka, Alena Skálová

Abstract read
PubMed Publisher
In one paragraph

Article in Virchows Archiv : an international journal of pathology, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed, 2 pooled it
4.3field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 2 syntheses or guidelines pooled it, 41 citations in OpenAlex.

  1. S1 guideline sweat gland carcinoma.Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG · 2026
    Guideline
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Review
  16. Molecular pathology in diagnosis and prognostication of head and neck tumors.Virchows Archiv : an international journal of pathology · 2024
    Review
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 4 institutions in 3 countries.

Petr ŠteinerDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic. steiner@biopticka.cz.ORCID http://orcid.org/0000-0003-0320-8061
Simon AndreasenDepartment of Otorhinolaryngology Head and Neck Surgery and Audiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
Petr GrossmannBioptic Laboratory, Ltd, Molecular Pathology Laboratory, Mikulášské náměstí 4, 326 00, Plzen, Czech Republic.
Lukáš HauerDepartment of Maxillofacial Surgery, Faculty of Medicine in Plzen, Clinic of Dentistry, Charles University, Plzen, Czech Republic.
Tomáš VaněčekDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic.
Markéta MiesbauerováDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic.
Thalita SantanaDepartment of Oral Pathology, Faculty of Dentistry, University of São Paulo, São Paulo, Brazil.
Katalin KissDepartment of Pathology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
David SloukaDepartment of Otorhinolaryngology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic.
Alena SkálováDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, Plzen, Czech Republic.
Charles University · CZCopenhagen University Hospital · DKBiopticka Laborator (Czechia) · CZUniversidade de São Paulo · BR

Funding

Ministerstvo Školství, Mládeže a Tělovýchovy SVV-2017-260 391
6 · The paper itself

Abstract

Adenoid cystic carcinoma (AdCC) of the salivary glands is characterized by MYB-NFIB or MYBL1-NFIB fusion, prolonged but relentlessly progressive clinical course with frequent recurrences, and development of distant metastasis resulting in high long-term mortality. Currently, no effective therapy is available for patients with advanced non-resectable and/or metastatic disease. Complicating the clinical management of this patient group is the lack of prognostic markers. The purpose of this study is to investigate the prognostic value of 1p36 loss in patients with AdCC. The presence of 1p36 deletion and gene fusions involving the MYB, NFIB, and MYBL1 genes in a cohort of 93 salivary gland AdCCs was studied using fluorescence in situ hybridization. These results were statistically correlated with clinical data and outcome. Deletion of 1p36 in AdCC was identified in 13 of 85 analyzable cases (15.29%). MYB-NFIB fusion was detected in 57/85 (67.1%), MYBL1-NFIB fusion in 12/85 (14.1%), MYB-X fusion in 4/85 (4.7%), MYBL1-X in 4/85 (4.7%), and NFIB-X in 2/85 (2.4%) of AdCC cases. None of the 1p36-deleted samples showed MYBL1 rearrangement. Statistical analysis demonstrated a significant correlation between 1p36 deletion and advanced tumor stage and solid histology (p = 0.0061 and 0.0007, respectively). Kaplan-Meier survival curves showed statistically significant correlations between 1p36 deletion and decreased overall survival, disease-specific survival, recurrence-free interval, and recurrence-free survival, all of which were maintained in multivariate analysis. We demonstrate that 1p36 deletion can serve as an indicator of unfavorable outcome of patients with salivary gland AdCC.

Indexed as

Chromosome DeletionChromosomes, Human, Pair 1AdolescentAdultAgedAged, 80 and overBiomarkers, TumorCarcinoma, Adenoid CysticDisease-Free SurvivalDisease ProgressionGene FusionGenetic Predisposition to DiseaseHumansImmunohistochemistryIn Situ Hybridization, FluorescenceKaplan-Meier EstimateBiomarkers, TumorMYBL1 protein, humanMYB-NFIB fusion protein, humanNFIB protein, humanNFI Transcription FactorsOncogene Proteins, FusionProto-Oncogene ProteinsTrans-Activators1p36 locus deletionAdenoid cystic carcinomaMYB-NFIBPrognosisSalivary gland

Identifiers

PMID29619555
OpenAlexW2795728165

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.